http://altimmune.com
Altimmune, Inc. Company Intro
Altimmune is a clinical stage biopharmaceutical company focused on developing treatments for liver disease and immune modulating therapies. Our diverse pipeline includes treatments for NASH (ALT-801), chronic Hepatitis B, and conjugated immunostimulants for the treatment of cancer. In addition, we are developing intranasal vaccine & therapeutic candidates for anthrax, influenza and COVID-19.
Industry
Healthcare
Altimmune, Inc. Headquaters
910 Clopper Road
Gaithersburg,20878
United States
Altimmune, Inc. Share price
22 Oct 2020 01:04 GMT
$11.28
-0.11 (-0.97 %)
Altimmune, Inc. Market cap
$363.675 M
WMC RANKING
2020
Altimmune, Inc. # 189
BiotechnologyLatest Altimmune, Inc. News
21 Oct 2020
Pay Attention to this Trade Activity as Altimmune Inc. (ALT) last week performance was -19.90%
Altimmune Inc. (NASDAQ: ALT) flaunted slowness of -6.56% at $11.39, as the Stock market unbolted on October 20, 2020. During the day, the stock rose to ...
21 Oct 2020
EPS Surprise As An Investment Strategy: Altimmune Inc. (ALT), Spectrum Pharmaceuticals Inc. (SPPI)
The total Institutional investors and hedge funds own 45.90% of the company's stock. In the most recent purchasing and selling session, Altimmune Inc. (ALT)'s ...
22 Oct 2020
Biodefense Market Prices Analysis 2020-2025 – TechnoWeekly
Altimmune Inc. ANP Technologies Inc. Bavarian Nordic AS Cleveland BioLabs Inc. Elusys Therapeutics Inc. Emergent BioSolutions Inc. General Dynamics Corp.
WMC Market Score
WMC Market to Revenue Score
| Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score | |
| Altimmune, Inc. | 0.08 | 0 | 0 | 0 | 0 | 0 | 0 |
| Alexion Pharmaceuticals, Inc. | 100 | 13.15 | 100 | 19 | 0 | 0 | 98.93 |
| Vertex Pharmaceuticals Incorporated | 97.58 | 100 | 3.89 | 30 | 0 | 0 | 100 |
| 3SBio Inc. | 96.05 | 0 | 0 | 4 | 0 | 0 | 3.02 |
| Incyte Corporation | 40.27 | 14.26 | 7.06 | 100 | 0 | 0 | 90.93 |
Altimmune, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Altimmune, Inc. | $4,154 | $44,464 | $-35,689 | $374.865M | 189 |
| Alexion Pharmaceuticals, Inc. | $5,536,800 | $2,523,000 | $846,100 | $27.177B | 1 |
| Vertex Pharmaceuticals Incorporated | $5,402,685 | $2,634,428 | $2,080,775 | $55.881B | 2 |
| 3SBio Inc. | ¥5,318,091 | ¥3,085,221 | ¥973,717 | ¥20.867B | 3 |
| Incyte Corporation | $2,229,409 | $1,622,822 | $446,906 | $19.532B | 4 |